Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03404713 · ClinicalTrials.gov registry record · NA

Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating

A NA study, sponsored by Virginia Commonwealth University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT03404713: Clinical Trial NA study, sponsored by Virginia Commonwealth University.

NCT03404713 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03404713, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

There are limited evidence-based treatments for adolescents with binge eating and fewer specifically targeting adolescents with both binge eating and overweight/obesity. The existing research for adolescents with overweight/obesity and loss of control (LOC) eating supports a stepped-care model of treatment in which enhanced behavioral weight loss treatment is the first line of treatment followed by more intensive therapeutic treatment for individuals with remaining emotional eating difficulties. Thus, in this proposed study, the investigators will systematically develop a stepped-care protocol and manualized interventions for adolescents with LOC and binge eating behaviors. The investigators will then evaluate the feasibility and acceptability of the interventions in a pilot trial and gather preliminary outcome data to inform development of a subsequent randomized controlled trial.

Primary Outcome

The overeating module of the Eating Disorder Examination (EDE) assesses frequency of adolescents' objective and subjective binge and loss-of-control eating episodes during the last 28 days. Change in frequency of these episodes from baseline will be assessed at 4 weeks and 16 weeks.

Interventions

  • BEHAVIORAL Pathways to Health
  • BEHAVIORAL Be4U

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2018-02-15
Est. Completion 2018-11-07
Phase NA
Virginia Commonwealth University

558 total trials

Why NCT03404713 stopped before completion

NCT03404713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Pathways to Health is the first listed.

NCT03404713 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03404713 about?

NCT03404713 is a clinical study titled "Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating". There are limited evidence-based treatments for adolescents with binge eating and fewer specifically targeting adolescents with both binge eating and overweight/obesity. The existing research for adolescents with overweight/obesity and loss of control (LOC) eating supports a stepped-care model of tr...

What is the current status of trial NCT03404713?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-02-15. Estimated completion is 2018-11-07.

What interventions are being tested in trial NCT03404713?

The interventions under investigation include: Pathways to Health (BEHAVIORAL), Be4U (BEHAVIORAL).

Who is sponsoring clinical trial NCT03404713?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03404713's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03404713, the US trial registry maintained by the National Library of Medicine. NCT03404713 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.